Omicron News and Research

RSS
Study shows the benefits of locally administered intranasal live-attenuated SARS-CoV-2 vaccine

Study shows the benefits of locally administered intranasal live-attenuated SARS-CoV-2 vaccine

SARS-CoV-2-infection and vaccine-induced antibodies wane initially but stabilize for lasting protection

SARS-CoV-2-infection and vaccine-induced antibodies wane initially but stabilize for lasting protection

Neonates of booster-vaccinated mothers have lower COVID-19 risk and better outcomes

Neonates of booster-vaccinated mothers have lower COVID-19 risk and better outcomes

Increased paxlovid use could lead to significant hospitalization reductions and cost savings

Increased paxlovid use could lead to significant hospitalization reductions and cost savings

Study reveals high prevalence of persistent COVID-19 infections in general population

Study reveals high prevalence of persistent COVID-19 infections in general population

Understanding the varied impact of COVID-19 in Shanghai and Hong Kong: A comparative analysis

Understanding the varied impact of COVID-19 in Shanghai and Hong Kong: A comparative analysis

Study shows ritonavir-boosted nirmatrelvir remains effective against new omicron variants in the U.S

Study shows ritonavir-boosted nirmatrelvir remains effective against new omicron variants in the U.S

COVID-19's lasting impact on smell and brain health unveiled

COVID-19's lasting impact on smell and brain health unveiled

Long COVID in children: A closer look reveals lasting impacts

Long COVID in children: A closer look reveals lasting impacts

Understanding the virological properties of SARS-CoV-2 variant JN.1

Understanding the virological properties of SARS-CoV-2 variant JN.1

MHRA authorizes COVID-19 vaccines: Comirnaty and Nuvaxovid gain approvals

MHRA authorizes COVID-19 vaccines: Comirnaty and Nuvaxovid gain approvals

XBB.1.5 updated COVID vaccine booster offers 54% increased protection against symptomatic infection

XBB.1.5 updated COVID vaccine booster offers 54% increased protection against symptomatic infection

Evaluating effectiveness of various COVID-19 vaccine doses after primary vaccination

Evaluating effectiveness of various COVID-19 vaccine doses after primary vaccination

Immunocompromised patients show prolonged SARS-CoV-2 infection and unique mutations

Immunocompromised patients show prolonged SARS-CoV-2 infection and unique mutations

Neonates exposed to SARS-CoV-2 in utero at higher risk of respiratory distress, study finds

Neonates exposed to SARS-CoV-2 in utero at higher risk of respiratory distress, study finds

Study offers insights into who's at risk for long COVID among immunocompromised patients

Study offers insights into who's at risk for long COVID among immunocompromised patients

UK Biobank research reveals significant impact of type 2 diabetes on COVID-19 outcomes

UK Biobank research reveals significant impact of type 2 diabetes on COVID-19 outcomes

Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine

Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine

UKHSA unveils groundbreaking Pathogen Genomics Strategy for pandemic preparedness

UKHSA unveils groundbreaking Pathogen Genomics Strategy for pandemic preparedness

Effects of varying COVID-19 vaccination rates on population-level health outcomes across variant waves in the U.S.

Effects of varying COVID-19 vaccination rates on population-level health outcomes across variant waves in the U.S.